STERIS plc (STE) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.042x

Based on the latest financial reports, STERIS plc (STE) has a cash flow conversion efficiency ratio of 0.042x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($298.20 Million) by net assets ($7.17 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See STERIS plc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

STERIS plc - Cash Flow Conversion Efficiency Trend (1991–2025)

This chart illustrates how STERIS plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

STERIS plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of STERIS plc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
HP Inc
NYSE:HPQ
0.112x
Zscaler Inc
NASDAQ:ZS
0.226x
SBA Communications Corp
NASDAQ:SBAC
-0.065x
OMV Aktiengesellschaft
VI:OMV
0.036x
Allegheny Technologies Incorporated
NYSE:ATI
0.165x
MPI Corporation
TWO:6223
0.102x
EXACT Sciences Corporation
NASDAQ:EXAS
0.063x
Fidelity National Information Services Inc
NYSE:FIS
0.076x

Annual Cash Flow Conversion Efficiency for STERIS plc (1991–2025)

The table below shows the annual cash flow conversion efficiency of STERIS plc from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see STE stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 $6.62 Billion $1.15 Billion 0.174x +12.60%
2024-03-31 $6.32 Billion $973.27 Million 0.154x +23.93%
2023-03-31 $6.09 Billion $756.95 Million 0.124x +18.84%
2022-03-31 $6.54 Billion $684.81 Million 0.105x -40.96%
2021-03-31 $3.89 Billion $689.64 Million 0.177x +2.23%
2020-03-31 $3.41 Billion $590.56 Million 0.173x +2.36%
2019-03-31 $3.19 Billion $539.50 Million 0.169x +19.06%
2018-03-31 $3.22 Billion $457.63 Million 0.142x -5.75%
2017-03-31 $2.81 Billion $424.09 Million 0.151x +80.08%
2016-03-31 $3.04 Billion $254.68 Million 0.084x -63.43%
2015-03-31 $1.07 Billion $246.04 Million 0.229x +13.83%
2014-03-31 $1.04 Billion $209.63 Million 0.201x -16.31%
2013-03-31 $946.98 Million $227.81 Million 0.241x +32.49%
2012-03-31 $822.66 Million $149.37 Million 0.182x +21.62%
2011-03-31 $788.66 Million $117.74 Million 0.149x -49.93%
2010-03-31 $754.49 Million $224.95 Million 0.298x +27.85%
2009-03-31 $717.74 Million $167.38 Million 0.233x +14.89%
2008-03-31 $706.48 Million $143.40 Million 0.203x +64.16%
2007-03-31 $774.29 Million $95.74 Million 0.124x -44.20%
2006-03-31 $730.83 Million $161.96 Million 0.222x +12.49%
2005-03-31 $755.64 Million $148.87 Million 0.197x +3.60%
2004-03-31 $679.06 Million $129.13 Million 0.190x -18.75%
2003-03-31 $569.53 Million $133.29 Million 0.234x -19.72%
2002-03-31 $487.14 Million $142.02 Million 0.292x +20.90%
2001-03-31 $424.38 Million $102.34 Million 0.241x +42.81%
2000-03-31 $421.09 Million $71.11 Million 0.169x +14.12%
1999-03-31 $435.90 Million $64.50 Million 0.148x +342.62%
1998-03-31 $358.95 Million $12.00 Million 0.033x -39.56%
1997-03-31 $294.70 Million $16.30 Million 0.055x -75.90%
1996-03-31 $304.10 Million $69.80 Million 0.230x -85.08%
1995-03-31 $44.60 Million $68.60 Million 1.538x +1766.96%
1994-03-31 $35.20 Million $2.90 Million 0.082x +216.60%
1993-03-31 $26.90 Million $700.00K 0.026x +108.62%
1992-03-31 $5.30 Million $-1.60 Million -0.302x -50.94%
1991-03-31 $1.50 Million $-300.00K -0.200x --

About STERIS plc

NYSE:STE USA Medical Devices
Market Cap
$19.87 Billion
Market Cap Rank
#1307 Global
#530 in USA
Share Price
$202.61
Change (1 day)
+1.61%
52-Week Range
$199.40 - $268.65
All Time High
$268.65
About

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital … Read more